RCRoman Cieslak

Roman Cieslak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Roman Cieslak has a total of 145 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multifaceted effects of direct and indirect trauma exposure on posttraumatic stress symptoms

    by Magdalena Lesnierowska, Roman Cieslak

    Although exposure to traumatic events is necessary for developing posttraumatic stress, the dose–response relationship between exposure and symptom severity remains inconclusive. One explanation may be the multifaceted nature of trauma exposure, with distinct exposure dimensions exerting differential effects on posttraumatic stress. We assessed four dimensions of trauma exposure—diversity, volume, frequency, and perceived severity—across four trauma exposure modalities: personal involvement in the traumatic event, witnessing, vicarious exposure through close others, and work-related indirect trauma exposure. A nationwide survey of Polish adults ( N = 808) assessed exposure using the Multidimensional Trauma Exposure Scale and posttraumatic stress symptoms using the PTSD Checklist for DSM-5. A multiple-indicator multiple-cause structural equation model evaluated 16 dimension-by-modality trauma exposure predictors. Within the direct trauma exposure modality, both frequency of exposure ( β = 0.14, SE = 0.05, 95% CI [0.04, 0.23]) and perceived severity of exposure ( β = 0.22, SE = 0.05, 95% CI [0.13, 0.31]) were positively associated with posttraumatic stress symptoms. Additionally, the perceived severity of trauma experienced by close others significantly predicted the outcome ( β = 0.08, SE = 0.04, 95% CI [0.00, 0.16]). No exposure dimensions within witnessing or occupational exposure were significantly linked to posttraumatic stress. These findings suggest that separate dimensions of trauma exposure operate through distinct pathways across trauma exposure modalities, with subjective appraisal of exposure severity emerging as the strongest predictor. Simultaneously modeling multiple trauma exposure dimensions and modalities may improve posttraumatic stress risk assessment, providing a theoretically grounded framework for future assessment protocols and intervention research.

  • Open Access

    Clinical Effectiveness and Cost-Effectiveness of Blended Treatment for Major Depression Compared With Treatment as Usual Within Routine Care in Europe: A Noninferiority Randomized Controlled Trial

    by Heleen Riper, Annet Kleiboer, Adriaan Hoogendoorn, Judith Bosmans, Mieke Schulte, Kim Mathiasen, Jean Baptiste Hazo, Jerome Holtzmann, Karine Chevreul, David Daniel Ebert, et al.

    Background: Cognitive behavioral therapy (CBT) is an effective and widely used treatment for major depressive disorder (MDD). However, access is limited by long waiting lists and a shortage of trained therapists. Evidence-based guided and self-guided digital interventions can address these challenges, but their large-scale adoption in routine primary and specialized mental health care has been slow. Blended CBT (bCBT), combining face-to-face therapy with structured, guided digital treatment modules, may increase treatment capacity while maintaining the benefits of therapist support. Objective: The European Comparative Effectiveness Research on Internet-based Depression Treatment study, conducted across 9 European countries, is the first large-scale comparative bCBT study for MDD. The hypothesis was that bCBT is clinically noninferior and cost-effective when compared with treatment as usual (TAU), which mainly consisted of face-to-face CBT. Methods: A multisite randomized controlled trial was conducted with a noninferiority margin of d =0.20. Main inclusion criteria were age ≥18 years, a diagnosis of MDD based on the Mini International Neuropsychiatric Interview, and a baseline Patient Health Questionnaire-9 (PHQ-9) score of ≥5. The primary outcome was the PHQ-9, with secondary outcomes including MDD remission at 12 months, therapeutic alliance, and costs. Intention-to-treat analyses were performed, and linear mixed modeling was used to assess intervention effects. Cost-effectiveness analyses were conducted from a health care perspective. Results: A total of 835 patients were included in the study. bCBT was shown to be noninferior to TAU on the primary PHQ-9 outcome during treatment (3 months after the baseline assessment, d =−0.26, 95% CI −0.43 to −0.09), at 6 months (posttreatment, d =−0.21, 95% CI −0.39 to−0.04), and at 12-month follow-up ( d =−0.01, 95% CI −0.19 to 0.17). Furthermore, the bCBT group had a significantly lower likelihood of experiencing an MDD episode at 12 months (odds ratio 0.67, 95% CI 0.45‐0.99). Subgroup analyses indicated that participants with and with no antidepressant use at baseline in both groups benefited equally from their treatment. Deterioration rates (Reliable Change Index) were below 5% in both groups. bCBT appeared acceptable for patients and therapists, with a strong working alliance in both groups. From a health care perspective, bCBT was not cost-effective at 12 months' assessment, as its total costs were not significantly lower than TAU. However, the probability that bCBT is cost-effective is high (0.95) at a willingness to pay (WTP) of €3800 per improvement in the PHQ-9 score, and 0.76 at a WTP of €10,000 per MDD case prevented (average 2017 exchange rate was €1=US $1.13). Conclusions: bCBT offers an effective and safe digitally supported alternative to face-to-face TAU for patients with MDD and their therapists in routine clinical care. From a health care perspective, its cost-effectiveness depends on policymakers’ WTP for the additional clinical benefits achieved.

  • Open Access

    Beyond Direct Trauma: Epidemiology of Exposure Modalities, Event Types, and PTSD in a National Polish Sample

    by Magdalena Leśnierowska, Roman Cieślak

    The epidemiological literature on trauma has largely centered on direct exposure, leaving other exposure pathways underexamined. We broaden this perspective by (1) mapping population-wide trauma exposure across four modalities—direct personal exposure, witnessing, indirect exposure via a close other, and work-related indirect exposure—and (2) estimating event-specific conditional risk of PTSD within each trauma exposure modality, with particular attention to indirect and multimodal exposures. Data came from a national sample of Polish adults (N = 808) collected in 2017. Trauma exposure was assessed with the Multidimensional Trauma Exposure Scale (MTES) and PTSD with the PTSD Checklist for DSM-5 (PCL-5). Trauma exposure was nearly universal (95.1%). Modality-specific exposure rates were 89.5% (direct), 78.9% (witnessed), 63.7% (via close other), and 29.4% (occupational), with significant gender-specific patterns. PTSD prevalence was 23.8%, higher in women than men (26.7% vs. 15.1%; OR = 2.09, 95% CI [1.47, 2.97]). Notably, all PTSD cases reported multimodal exposure. Event-specific patterns within modalities were associated with elevated PTSD risk. These findings show the trauma landscape extends far beyond direct events: indirect and multimodal exposures are common and consequential, suggesting PTSD often reflects the cumulative burden of overlapping exposures. Representing the pre-COVID-19 landscape, the findings constitute a critical baseline for evaluating the subsequent surge in mental health challenges. Consequently, public health surveillance should systematically incorporate these broader exposure pathways to monitor epidemiological trends while requiring rigorous operationalization to avoid diagnostic inflation.

  • Open Access

    Meta Self-Efficacy Internet Intervention to Support Occupational Health in Young Employees: Protocol for Co-Creation and a Randomized Controlled Trial

    by Jan Maciejewski, Roman Cieslak, Per Carlbring, Ewelina Smoktunowicz

    Background: Supporting young employees as they navigate the changing workplace requires focus on personal resources. Although self-efficacy is a key and malleable resource, its context specificity limits its applicability. To address this, we propose to target meta self-efficacy, a construct reflecting an individual’s ability to leverage self-efficacy sources (mastery experiences, vicarious experiences, persuasion, and affective and physiological states) to build self-efficacy specific to any challenge and, in turn, safeguard their occupational health. Objective: The goal of this study is to co-create (co-creation phase) and verify the efficacy (randomized controlled trial [RCT] phase) of an internet intervention enhancing meta self-efficacy to support the occupational health of young employees. Methods: The co-creation phase will be based on the participatory approach principle and comprise 4 focus groups, where a total of 24 participants will contribute to meta self-efficacy–enhancing activities and identify needs for the intervention format. After each focus group, a preliminary qualitative analysis will be conducted, and the intervention draft will be refined. To detect an effect size of d=0.25, the RCT will use a 2-arm parallel design with a total sample size of 600 comparing the meta self-efficacy intervention against a placebo. Assessments will be conducted at the posttest time point and 3- and 6-month follow-ups, with work self-efficacy as the primary outcome and job stress, job affective well-being, and work capabilities as secondary outcomes, as well as meta self-efficacy as the manipulation check. Data will be analyzed using linear mixed-effects models following the intention-to-treat approach. The trial will also examine the impact of adherence and engagement on intervention outcomes and compare treatment credibility. Results: As of November 20, 2025, a total of 24 participants have been recruited, with 3 of 4 focus groups conducted and the final one to be completed by the end of 2025. RCT recruitment is scheduled to start at the beginning of 2026, with the last follow-up expected by the end of 2026. Conclusions: In comparison to the placebo control, we expect the intervention to significantly improve young employees’ work self-efficacy (primary outcome) and occupational well-being (secondary outcomes). If effective, the meta self-efficacy–enhancing intervention could bolster the ability to cope with various challenges in the health domain and beyond, extending the effect beyond the initial occupational context. Trial Registration: ClinicalTrials.gov NCT06944990; https://clinicaltrials.gov/study/NCT06944990 International Registered Report Identifier (IRRID): PRR1-10.2196/85082


  • Open Access

    Meta Self-Efficacy Internet Intervention to Support Occupational Health in Young Employees: Protocol for Co-Creation and a Randomized Controlled Trial (Preprint)

    by Jan Maciejewski, Roman Cieslak, Per Carlbring, Ewelina Smoktunowicz

    BACKGROUND Supporting young employees as they navigate the changing workplace requires focus on personal resources. Although self-efficacy is a key and malleable resource, its context specificity limits its applicability. To address this, we propose to target meta self-efficacy, a construct reflecting an individual’s ability to leverage self-efficacy sources (mastery experiences, vicarious experiences, persuasion, and affective and physiological states) to build self-efficacy specific to any challenge and, in turn, safeguard their occupational health. OBJECTIVE The goal of this study is to co-create (co-creation phase) and verify the efficacy (randomized controlled trial [RCT] phase) of an internet intervention enhancing meta self-efficacy to support the occupational health of young employees. METHODS The co-creation phase will be based on the participatory approach principle and comprise 4 focus groups, where a total of 24 participants will contribute to meta self-efficacy–enhancing activities and identify needs for the intervention format. After each focus group, a preliminary qualitative analysis will be conducted, and the intervention draft will be refined. To detect an effect size of d=0.25, the RCT will use a 2-arm parallel design with a total sample size of 600 comparing the meta self-efficacy intervention against a placebo. Assessments will be conducted at the posttest time point and 3- and 6-month follow-ups, with work self-efficacy as the primary outcome and job stress, job affective well-being, and work capabilities as secondary outcomes, as well as meta self-efficacy as the manipulation check. Data will be analyzed using linear mixed-effects models following the intention-to-treat approach. The trial will also examine the impact of adherence and engagement on intervention outcomes and compare treatment credibility. RESULTS As of November 20, 2025, a total of 24 participants have been recruited, with 3 of 4 focus groups conducted and the final one to be completed by the end of 2025. RCT recruitment is scheduled to start at the beginning of 2026, with the last follow-up expected by the end of 2026. CONCLUSIONS In comparison to the placebo control, we expect the intervention to significantly improve young employees’ work self-efficacy (primary outcome) and occupational well-being (secondary outcomes). If effective, the meta self-efficacy–enhancing intervention could bolster the ability to cope with various challenges in the health domain and beyond, extending the effect beyond the initial occupational context. CLINICALTRIAL ClinicalTrials.gov NCT06944990; https://clinicaltrials.gov/study/NCT06944990 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/85082

  • Open Access

    Clinical psychology and the COVID-19 pandemic: A mixed methods survey among members of the European Association of Clinical Psychology and Psychological Treatment (EACLIPT)

    by Julia Asbrand, Samantha Gerdes, Josefien Breedvelt, Jenny Guidi, Colette Hirsch, Andreas Maercker, Céline Douilliez, Gerhard Andersson, Martin Debbané, Roman Cieslak, et al.

    Background: The COVID-19 pandemic has affected people globally both physically and psychologically. The increased demands for mental health interventions provided by clinical psychologists, psychotherapists and mental health care professionals, as well as the rapid change in work setting (e.g., from face-to-face to video therapy) has proven challenging. The current study investigates European clinical psychologists and psychotherapists’ views on the changes and impact on mental health care that occurred due to the COVID-19 pandemic. It further aims to explore individual and organizational processes that assist clinical psychologists’ and psychotherapists’ in their new working conditions, and understand their needs and priorities. Method: Members of the European Association of Clinical Psychology and Psychological Treatment (EACLIPT) were invited (N = 698) to participate in a survey with closed and open questions covering their experiences during the first wave of the pandemic from June to September 2020. Participants (n = 92) from 19 European countries, mostly employed in universities or hospitals, completed the online survey. Results: Results of qualitative and quantitative analyses showed that clinical psychologists and psychotherapists throughout the first wave of the COVID-19 pandemic managed to continue to provide treatments for patients who were experiencing emotional distress. The challenges (e.g., maintaining a working relationship through video treatment) and opportunities (e.g., more flexible working hours) of working through this time were identified. Conclusions: Recommendations for mental health policies and professional organizations are identified, such as clear guidelines regarding data security and workshops on conducting video therapy.


  • Open Access

    Effect of Sleep Disturbance Symptoms on Treatment Outcome in Blended Cognitive Behavioral Therapy for Depression (E-COMPARED Study): Secondary Analysis

    by Kazuki Matsumoto, Hugh McCall, Esben Skov Jensen, Nicolai Ladegaard, Angelina Isabella Mellentin, David Daniel Ebert, Ingrid Titzler, Ricardo Araya, Arlinda Cerga Pashoja, Jean-Baptiste Hazo, et al.

    Background: Sleep disturbance symptoms are common in major depressive disorder (MDD) and have been found to hamper the treatment effect of conventional face-to-face psychological treatments such as cognitive behavioral therapy. To increase the dissemination of evidence-based treatment, blended cognitive behavioral therapy (bCBT) consisting of web-based and face-to-face treatment is on the rise for patients with MDD. To date, no study has examined whether sleep disturbance symptoms have an impact on bCBT treatment outcomes and whether it affects bCBT and treatment-as-usual (TAU) equally. Objective: The objectives of this study are to investigate whether baseline sleep disturbance symptoms have an impact on treatment outcomes independent of treatment modality and whether sleep disturbance symptoms impact bCBT and TAU in routine care equally. Methods: The study was based on data from the E-COMPARED (European Comparative Effectiveness Research on Blended Depression Treatment Versus Treatment-as-Usual) study, a 2-arm, multisite, parallel randomized controlled, noninferiority trial. A total of 943 outpatients with MDD were randomized to either bCBT (476/943, 50.5%) or TAU consisting of routine clinical MDD treatment (467/943, 49.5%). The primary outcome of this study was the change in depression symptom severity at the 12-month follow-up. The secondary outcomes were the change in depression symptom severity at the 3- and 6-month follow-up and MDD diagnoses at the 12-month follow-up, assessed using the Patient Health Questionnaire-9 and Mini-International Neuropsychiatric Interview, respectively. Mixed effects models were used to examine the association of sleep disturbance symptoms with treatment outcome and treatment modality over time. Results: Of the 943 patients recruited for the study, 558 (59.2%) completed the 12-month follow-up assessment. In the total sample, baseline sleep disturbance symptoms did not significantly affect change in depressive symptom severity at the 12-month follow-up (β=.16, 95% CI –0.04 to 0.36). However, baseline sleep disturbance symptoms were negatively associated with treatment outcome for bCBT (β=.49, 95% CI 0.22-0.76) but not for TAU (β=–.23, 95% CI −0.50 to 0.05) at the 12-month follow-up, even when adjusting for baseline depression symptom severity. The same result was seen for the effect of sleep disturbance symptoms on the presence of depression measured with Mini-International Neuropsychiatric Interview at the 12-month follow-up. However, for both treatment formats, baseline sleep disturbance symptoms were not associated with depression symptom severity at either the 3- (β=.06, 95% CI −0.11 to 0.23) or 6-month (β=.09, 95% CI −0.10 to 0.28) follow-up. Conclusions: Baseline sleep disturbance symptoms may have a negative impact on long-term treatment outcomes in bCBT for MDD. This effect was not observed for TAU. These findings suggest that special attention to sleep disturbance symptoms might be warranted when MDD is treated with bCBT. Future studies should investigate the effect of implementing modules specifically targeting sleep disturbance symptoms in bCBT for MDD to improve long-term prognosis.


  • Open Access

    Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study

    by Claire Rosalie van Genugten, Josien Schuurmans, Adriaan W Hoogendoorn, Ricardo Araya, Gerhard Andersson, Rosa Baños, Cristina Botella, Arlinda Cerga Pashoja, Roman Cieslak, David Daniel Ebert, et al.

    Background: Behavioral activation (BA), either as a stand-alone treatment or as part of cognitive behavioral therapy, has been shown to be effective for treating depression. The theoretical underpinnings of BA derive from Lewinsohn et al’s theory of depression. The central premise of BA is that having patients engage in more pleasant activities leads to them experiencing more pleasure and elevates their mood, which, in turn, leads to further (behavioral) activation. However, there is a dearth of empirical evidence about the theoretical framework of BA. Objective: This study aims to examine the assumed (temporal) associations of the 3 constructs in the theoretical framework of BA. Methods: Data were collected as part of the “European Comparative Effectiveness Research on Internet-based Depression Treatment versus treatment-as-usual” trial among patients who were randomly assigned to receive blended cognitive behavioral therapy (bCBT). As part of bCBT, patients completed weekly assessments of their level of engagement in pleasant activities, the pleasure they experienced as a result of these activities, and their mood over the course of the treatment using a smartphone-based ecological momentary assessment (EMA) application. Longitudinal cross-lagged and cross-sectional associations of 240 patients were examined using random intercept cross-lagged panel models. Results: The analyses did not reveal any statistically significant cross-lagged coefficients (all P>.05). Statistically significant cross-sectional positive associations between activities, pleasure, and mood levels were identified. Moreover, the levels of engagement in activities, pleasure, and mood slightly increased over the duration of the treatment. In addition, mood seemed to carry over, over time, while both levels of engagement in activities and pleasurable experiences did not. Conclusions: The results were partially in accordance with the theoretical framework of BA, insofar as the analyses revealed cross-sectional relationships between levels of engagement in activities, pleasurable experiences deriving from these activities, and enhanced mood. However, given that no statistically significant temporal relationships were revealed, no conclusions could be drawn about potential causality. A shorter measurement interval (eg, daily rather than weekly EMA reports) might be more attuned to detecting potential underlying temporal pathways. Future research should use an EMA methodology to further investigate temporal associations, based on theory and how treatments are presented to patients. Trial Registration: ClinicalTrials.gov, NCT02542891, https://clinicaltrials.gov/ct2/show/NCT02542891; German Clinical Trials Register, DRKS00006866, https://tinyurl.com/ybja3xz7; Netherlands Trials Register, NTR4962, https://www.trialregister.nl/trial/4838; ClinicalTrials.Gov, NCT02389660, https://clinicaltrials.gov/ct2/show/NCT02389660; ClinicalTrials.gov, NCT02361684, https://clinicaltrials.gov/ct2/show/NCT02361684; ClinicalTrials.gov, NCT02449447, https://clinicaltrials.gov/ct2/show/NCT02449447; ClinicalTrials.gov, NCT02410616, https://clinicaltrials.gov/ct2/show/NCT02410616; ISRCTN registry, ISRCTN12388725, https://www.isrctn.com/ISRCTN12388725


  • Open Access

    Examining the Theoretical Framework of Behavioral Activation for Major Depressive Disorder: Smartphone-Based Ecological Momentary Assessment Study (Preprint)

    by Claire Rosalie van Genugten, Josien Schuurmans, Adriaan W Hoogendoorn, Ricardo Araya, Gerhard Andersson, Rosa Baños, Cristina Botella, Arlinda Cerga Pashoja, Roman Cieslak, David Daniel Ebert, et al.

    BACKGROUND Behavioral activation (BA), either as a stand-alone treatment or as part of cognitive behavioral therapy, has been shown to be effective for treating depression. The theoretical underpinnings of BA derive from Lewinsohn et al’s theory of depression. The central premise of BA is that having patients engage in more pleasant activities leads to them experiencing more pleasure and elevates their mood, which, in turn, leads to further (behavioral) activation. However, there is a dearth of empirical evidence about the theoretical framework of BA. OBJECTIVE This study aims to examine the assumed (temporal) associations of the 3 constructs in the theoretical framework of BA. METHODS Data were collected as part of the “European Comparative Effectiveness Research on Internet-based Depression Treatment versus treatment-as-usual” trial among patients who were randomly assigned to receive blended cognitive behavioral therapy (bCBT). As part of bCBT, patients completed weekly assessments of their level of engagement in pleasant activities, the pleasure they experienced as a result of these activities, and their mood over the course of the treatment using a smartphone-based ecological momentary assessment (EMA) application. Longitudinal cross-lagged and cross-sectional associations of 240 patients were examined using random intercept cross-lagged panel models. RESULTS The analyses did not reveal any statistically significant cross-lagged coefficients (all P>.05). Statistically significant cross-sectional positive associations between activities, pleasure, and mood levels were identified. Moreover, the levels of engagement in activities, pleasure, and mood slightly increased over the duration of the treatment. In addition, mood seemed to carry over, over time, while both levels of engagement in activities and pleasurable experiences did not. CONCLUSIONS The results were partially in accordance with the theoretical framework of BA, insofar as the analyses revealed cross-sectional relationships between levels of engagement in activities, pleasurable experiences deriving from these activities, and enhanced mood. However, given that no statistically significant temporal relationships were revealed, no conclusions could be drawn about potential causality. A shorter measurement interval (eg, daily rather than weekly EMA reports) might be more attuned to detecting potential underlying temporal pathways. Future research should use an EMA methodology to further investigate temporal associations, based on theory and how treatments are presented to patients. CLINICALTRIAL ClinicalTrials.gov, NCT02542891, https://clinicaltrials.gov/ct2/show/NCT02542891; German Clinical Trials Register, DRKS00006866, https://tinyurl.com/ybja3xz7; Netherlands Trials Register, NTR4962, https://www.trialregister.nl/trial/4838; ClinicalTrials.Gov, NCT02389660, https://clinicaltrials.gov/ct2/show/NCT02389660; ClinicalTrials.gov, NCT02361684, https://clinicaltrials.gov/ct2/show/NCT02361684; ClinicalTrials.gov, NCT02449447, https://clinicaltrials.gov/ct2/show/NCT02449447; ClinicalTrials.gov, NCT02410616, https://clinicaltrials.gov/ct2/show/NCT02410616; ISRCTN registry, ISRCTN12388725, https://www.isrctn.com/ISRCTN12388725

  • Open Access

    Resource-Based Internet Intervention (Med-Stress) to Improve Well-Being Among Medical Professionals: Randomized Controlled Trial

    by Ewelina Smoktunowicz, Magdalena Lesnierowska, Per Carlbring, Gerhard Andersson, Roman Cieslak

    Background: Medical professionals are exposed to multiple and often excessive demands in their work environment. Low-intensity internet interventions allow them to benefit from psychological support even when institutional help is not available. Focusing on enhancing psychological resources—self-efficacy and perceived social support—makes an intervention relevant for various occupations within the medical profession. Previously, these resources were found to operate both individually or sequentially with self-efficacy either preceding social support (cultivation process) or following it (enabling process). Objective: The objective of this randomized controlled trial is to compare the efficacy of 4 variants of Med-Stress, a self-guided internet intervention that aims to improve the multifaceted well-being of medical professionals. Methods: This study was conducted before the COVID-19 pandemic. Participants (N=1240) were recruited mainly via media campaigns and social media targeted ads. They were assigned to 1 of the following 4 groups: experimental condition reflecting the cultivation process, experimental condition reflecting the enabling process, active comparator enhancing only self-efficacy, and active comparator enhancing only perceived social support. Outcomes included 5 facets of well-being: job stress, job burnout, work engagement, depression, and job-related traumatic stress. Measurements were taken on the web at baseline (time 1), immediately after intervention (time 2), and at a 6-month follow-up (time 3). To analyze the data, linear mixed effects models were used on the intention-to-treat sample. The trial was partially blinded as the information about the duration of the trial, which was different for experimental and control conditions, was public. Results: At time 2, job stress was lower in the condition reflecting the cultivation process than in the one enhancing social support only (d=−0.21), and at time 3, participants in that experimental condition reported the lowest job stress when compared with all 3 remaining study groups (ds between −0.24 and −0.41). For job-related traumatic stress, we found a significant difference between study groups only at time 3: stress was lower in the experimental condition in which self-efficacy was enhanced first than in the active comparator enhancing solely social support (d=−0.24). The same result was found for work engagement (d=−0.20), which means that it was lower in exactly the same condition that was found beneficial for stress relief. There were no differences between study conditions for burnout and depression neither at time 2 nor at time 3. There was a high dropout in the study (1023/1240, 82.50% at posttest), reflecting the pragmatic nature of this trial. Conclusions: The Med-Stress internet intervention improves some components of well-being—most notably job stress—when activities are completed in a specific sequence. The decrease in work engagement could support the notion of dark side of this phenomenon, but further research is needed. Trial Registration: ClinicalTrials.gov NCT03475290; https://clinicaltrials.gov/ct2/show/NCT03475290 International Registered Report Identifier (IRRID): RR2-10.1186/s13063-019-3401-9